Sort by
Refine Your Search
-
Philanthropy and is fixed-term until 31 Dec 2027. A further extension to this would be based on funding availability. You will conduct hands-on empirical research in multi-agent security and agentic AI security
-
Philanthropy and is fixed-term until 31 Dec 2027. A further extension to this would be based on funding availability. You will conduct hands-on empirical research in multi-agent security and agentic AI security
-
up results clearly, and manage associated administrative duties effectively. Your expertise will include computational modelling of agent behaviour, practical development of agent models using symbolic
-
agentic architectures for autonomous scientific reasoning and planning; • AI social scientists, including language-model-based and agent-based simulations for social science domains such as history
-
for knowledge workers to better organise knowledge bases and maintain the integrity of their information. The post holder will work closely with Prof Elena Simperl and a team of 15+ researchers and PhD
-
agentic AI, as well as AI standards to create trustworthy information resources. This includes the design of algorithms, tools, and process for knowledge workers to better organise knowledge bases and
-
of Dr. Marios Kogias as part of his ERC Starting project titled CloudNG (https://cordis.europa.eu/project/id/101220079 ). The post will be based in the Department of Computing at Imperial College London
-
approaches, including advanced live cell imaging and in vitro motility assays. The position is based in Michael Way’s laboratory at the Francis Crick Institute. Click here to read more about the Way lab
-
, such as stateful serverless workflows and agentic AI. The project takes a clean-slate approach to cloud infrastructure by exploring new architectures, abstractions, and execution models towards designing
-
: The Patient as an Agent of Change, based at the University of Vienna. Beyond Thalidomide (2024-2029), funded by an ERC Starting Grant pioneers a history of the global rise of patient engagement with drug